Serial Next-Generation Sequencing of Circulating Cell-Free DNA Evaluating Tumor Clone Response To Molecularly Targeted Drug Administration by Frenel, Jean Sebastien, Carreira, Suzanne, Goodall, Jane, Roda, Desam, Perez-Lopez, Raquel, Tunariu, Nina, Riisnaes, Ruth, Miranda, Susana, Figueiredo, Ines, Nava-Rodrigues, Daniel, Smith, Alan, Leux, Christophe, Garcia-Murillas, Isaac, Ferraldeschi, Roberta, Lorente, David, Mateo, Joaquin, Ong, Michael, Yap, Timothy A, Banerji, Udai, Gasi Tandefelt, Delila, Turner, Nick, Attard, Gerhardt, de Bono, Johann S

Get full text

Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials by Lopez, Juanita, Harris, Sam, Roda, Desam, Yap, Timothy A

Get full text

Strategies for modern biomarker and drug development in oncology by Smith, Alan D, Roda, Desam, Yap, Timothy A

Get full text

Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study by Gambardella, Valentina, Lombardi, Pasquale, Carbonell-Asins, Juan Antonio, Tarazona, Noelia, Cejalvo, Juan Miguel, González-Barrallo, Inés, Martín-Arana, Jorge, Tébar-Martínez, Roberto, Viala, Alba, Bruixola, Gema, Hernando, Cristina, Blasco, Inma, Papaccio, Federica, Martínez-Ciarpaglini, Carolina, Alfaro-Cervelló, Clara, Seda-García, Enrique, Blesa, Sebastián, Chirivella, Isabel, Castillo, Josefa, Montón-Bueno, José Vicente, Roselló, Susana, Huerta, Marisol, Pérez-Fidalgo, Alejandro, Martín-Martorell, Paloma, Insa-Mollá, Amelia, Fleitas, Tania, Rentero-Garrido, Pilar, Zúñiga-Trejos, Sheila, Cervantes, Andrés, Roda, Desamparados

Get full text

Clinical outcomes and prognostic factors of patients with advanced mesothelioma treated in a phase I clinical trials unit by Papadatos-Pastos, Dionysis, Roda, Desam, De Miguel Luken, Maria Jose, Petruckevitch, Ann, Jalil, Awais, Capelan, Marta, Michalarea, Vasiliki, Lima, Joao, Diamantis, Nikolaos, Bhosle, Jaishree, Molife, L. Rhoda, Banerji, Udai, de Bono, Johann S, Popat, Sanjay, O'Brien, Mary E.R, Yap, Timothy A

Get full text

High frequency of radiological differential responses with poly(ADP-Ribose) polymerase (PARP) inhibitor therapy by Perez-Lopez, Raquel, Roda, Desam, Jimenez, Begona, Brown, Jessica, Mateo, Joaquin, Carreira, Suzanne, Lopez, Juanita, Banerji, Udai, Molife, L Rhoda, Koh, Dow-Mu, Kaye, Stan B, de Bono, Johann S, Tunariu, Nina, Yap, Timothy A

Get full text

Precision Medicine for Molecularly Targeted Agents and Immunotherapies in Early-Phase Clinical Trials by Lopez, Juanita, Harris, Sam, Roda, Desam, Yap, Timothy A

Get full text

Abstract CT010: Phase I trial combining the PARP inhibitor olaparib (Ola) and AKT inhibitor AZD5363 (AZD) in germline (g)BRCA and non-BRCA mutant (m) advanced cancer patients (pts)... by Michalarea, Vasiliki, Roda, Desam, Drew, Yvette, Carreira, Suzanne, O’Carrigan, Brent S., Shaw, Heather, Roux, Rene, Kumar, Sanjeev, Ward, Sarah, Parmar, Mona, Turner, Alison, Hall, Emma, Serrano Fandos, Sonia, Perez, Raquel, Tunariu, Nina, Raynaud, Florence, Cullberg, Marie, Foxley, Andrew, Lindemann, Justin PO, Pass, Martin, Rugman, Paul, Lopez, Juanita S., Banerji, Udai, Basu, Bristi, Plummer, Ruth, Kristeleit, Rebecca, de Bono, Johann S., Yap, Timothy A.

Get full text

Abstract PR14: Phase I trial of first-in-class ataxia telangiectasia-mutated and Rad3-related (ATR) inhibitor VX-970 as monotherapy (mono) or in combination with carboplatin (CP) i... by Yap, Timothy A., Luken, Maria J. de Miguel, O'Carrigan, Brent, Roda, Desam, Papadatos-Pastos, Dionysis, Lorente, David, Tunariu, Nina, Lopez, Raquel Perez, Gayle, Sasha, Riisnaes, Ruth, Figueiredo, Ines, Miranda, Susana, Carreira, Suzanne, Yang, Fang, Karan, Sharon, Penney, Marina, Pollard, John, Molife, L. Rhoda, Banerji, Udai, Asmal, Mohammed, Fields, Scott Z., Bono, Johann S. de

Get full text